These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25859977)

  • 21. Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner.
    Fry DC
    Curr Pharm Des; 2012; 18(30):4679-84. PubMed ID: 22650256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular rotors as conditionally fluorescent labels for rapid detection of biomolecular interactions.
    Goh WL; Lee MY; Joseph TL; Quah ST; Brown CJ; Verma C; Brenner S; Ghadessy FJ; Teo YN
    J Am Chem Soc; 2014 Apr; 136(17):6159-62. PubMed ID: 24494589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction.
    Green AI; Hobor F; Tinworth CP; Warriner S; Wilson AJ; Nelson A
    Chemistry; 2020 Aug; 26(47):10682-10689. PubMed ID: 32458465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecular weight protein-protein interaction antagonists: an insurmountable challenge?
    Dömling A
    Curr Opin Chem Biol; 2008 Jun; 12(3):281-91. PubMed ID: 18501203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Synthetic Approaches towards Small Molecule Reactivators of p53.
    Silva JL; Lima CGS; Rangel LP; Ferretti GDS; Pauli FP; Ribeiro RCB; da Silva TB; da Silva FC; Ferreira VF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hot, hotter, hottest.
    Dömling A
    Cell Cycle; 2009 Apr; 8(8):1112. PubMed ID: 19342883
    [No Abstract]   [Full Text] [Related]  

  • 27. Small-molecule modulation of p53 protein-protein interactions.
    Kuusk A; Boyd H; Chen H; Ottmann C
    Biol Chem; 2020 Jul; 401(8):921-931. PubMed ID: 32049643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction.
    Doveston RG; Kuusk A; Andrei SA; Leysen S; Cao Q; Castaldi MP; Hendricks A; Brunsveld L; Chen H; Boyd H; Ottmann C
    FEBS Lett; 2017 Aug; 591(16):2449-2457. PubMed ID: 28640363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics-based identification of novel natural mortalin-p53 abrogators as anticancer agents.
    Nagpal N; Goyal S; Dhanjal JK; Ye L; Kaul SC; Wadhwa R; Chaturvedi R; Grover A
    J Recept Signal Transduct Res; 2017 Feb; 37(1):8-16. PubMed ID: 27380217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective cell-free drug screening protocol for protein-protein interaction.
    Ashkenazi S; Plotnikov A; Bahat A; Dikstein R
    Anal Biochem; 2017 Sep; 532():53-59. PubMed ID: 28579488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists.
    Koes D; Khoury K; Huang Y; Wang W; Bista M; Popowicz GM; Wolf S; Holak TA; Dömling A; Camacho CJ
    PLoS One; 2012; 7(3):e32839. PubMed ID: 22427896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic detection methods for protein-protein interaction inhibitors].
    Kato M; Utata R; Tsuganezawa K; Tanaka A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1557-62. PubMed ID: 21089588
    [No Abstract]   [Full Text] [Related]  

  • 33. Stabilization of protein-protein interaction complexes through small molecules.
    Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
    Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives.
    Fang Y; Liao G; Yu B
    Acta Pharm Sin B; 2020 Jul; 10(7):1253-1278. PubMed ID: 32874827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of In Silico Filtering and Isothermal Titration Calorimetry for the Discovery of Small Molecule Inhibitors of MDM2.
    Alali H; Bloch I; Rapaport I; Rodrigues L; Sher I; Ansbacher T; Gal M
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression.
    Shi J; Jin X; Wang Y; Zhu T; Zhang D; Li Q; Zhong X; Deng Y; Shen J; Fan X
    Oncogenesis; 2022 Jul; 11(1):37. PubMed ID: 35780125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIMBAL v2: update of a database holding small molecules modulating protein-protein interactions.
    Higueruelo AP; Jubb H; Blundell TL
    Database (Oxford); 2013; 2013():bat039. PubMed ID: 23766369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protein network as a tool for finding novel drug targets.
    Strong M; Eisenberg D
    Prog Drug Res; 2007; 64():191, 193-215. PubMed ID: 17195476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D interaction hubs.
    Song Y
    Nat Chem Biol; 2018 Aug; 14(8):745. PubMed ID: 30018419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.